These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
428 related articles for article (PubMed ID: 33858326)
1. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial. Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326 [TBL] [Abstract][Full Text] [Related]
2. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA. Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of quantifying Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717 [TBL] [Abstract][Full Text] [Related]
4. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study. Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908 [TBL] [Abstract][Full Text] [Related]
5. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA. Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855 [TBL] [Abstract][Full Text] [Related]
6. Combined detection of SDC2/ADHFE1/PPP2R5C methylation in stool DNA for colorectal cancer screening. Li B; Liu S; Gao Y; Zheng L; Lu Y J Cancer Res Clin Oncol; 2023 Sep; 149(12):10241-10253. PubMed ID: 37270460 [TBL] [Abstract][Full Text] [Related]
7. A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized Trial. Kim CW; Kim H; Kim HR; Won DD; Nam WJ; Min BS; Oh TJ; An S; Lee SH Am J Gastroenterol; 2024 Aug; ():. PubMed ID: 39292188 [TBL] [Abstract][Full Text] [Related]
8. [Application study of stool-based methylated SDC2 test in the screening of colorectal neoplasms for physical examination population]. Wang L; Huang ZM; Jiang YY; Zhu M; Zhang N; Xiong FB; Zou HZ; Xu XH Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1767-1773. PubMed ID: 36536564 [No Abstract] [Full Text] [Related]
9. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer. Su WC; Kao WY; Chang TK; Tsai HL; Huang CW; Chen YC; Li CC; Hsieh YC; Yeh HJ; Chang CC; Wang JY Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33393623 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis. Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903 [TBL] [Abstract][Full Text] [Related]
12. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis. Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931 [TBL] [Abstract][Full Text] [Related]
13. Stool DNA Test of Methylated Niu F; Wen J; Fu X; Li C; Zhao R; Wu S; Yu H; Liu X; Zhao X; Liu S; Wang X; Wang J; Zou H Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1411-1419. PubMed ID: 28619831 [No Abstract] [Full Text] [Related]
14. Using Comorbidity Pattern Analysis to Detect Reliable Methylated Genes in Colorectal Cancer Verified by Stool DNA Test. Cheng YC; Wu PH; Chen YJ; Yang CH; Huang JL; Chou YC; Chang PK; Wen CC; Jao SW; Huang HH; Tsai YH; Pai TW Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680934 [TBL] [Abstract][Full Text] [Related]
15. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514 [TBL] [Abstract][Full Text] [Related]
16. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design. Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the clinical performance of Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561 [TBL] [Abstract][Full Text] [Related]
18. A systematic evaluation of stool DNA preparation protocols for colorectal cancer screening via analysis of DNA methylation biomarkers. Jin S; Ye Q; Hong Y; Dai W; Zhang C; Liu W; Guo Y; Zhu D; Zhang Z; Chen S; Wang Y; Li D; Ma W; Yang Z; Li J; Zheng Z; Luan J; Wu X; Jiang F; Xu C; Ding C Clin Chem Lab Med; 2020 Jul; 59(1):91-99. PubMed ID: 32673280 [TBL] [Abstract][Full Text] [Related]
19. [Study on the application value of fecal He Y; Xu FF; Zuo HJ; Chen W; Liu ZB; Liu ZB; Chen XZ; Hui QS; Zou GW; Cai ZB; Liu Y; Tan HS; Zhou HF; Wang JP Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Jul; 58(7):1020-1028. PubMed ID: 39034786 [No Abstract] [Full Text] [Related]
20. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer. Xu F; Yu S; Han J; Zong M; Tan Q; Zeng X; Fan L Clin Transl Gastroenterol; 2021 Aug; 12(8):e00386. PubMed ID: 34382948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]